40603cf4b72867079fb10d482dfda2cc.jpeg

UK starts real-time review of Moderna's COVID-19 vaccine candidate

UK starts real-time review of Moderna's COVID-19 vaccine candidateThe company has begun a rolling data submission from its vaccine candidate to UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for it to start its independent assessment of evidence as and when it becomes available. Moderna is among the frontrunners in the race to develop a vaccine for the new coronavirus, including Pfizer Inc, Johnson & Johnson and Astrazeneca – all in their late-stage trials, interim data from which are expected in the coming weeks.


Source link

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email

Leave a Reply